FR2926994B1 - Nouveau procede pour la preparation d'extraits de ginkgo biloba - Google Patents

Nouveau procede pour la preparation d'extraits de ginkgo biloba

Info

Publication number
FR2926994B1
FR2926994B1 FR0800625A FR0800625A FR2926994B1 FR 2926994 B1 FR2926994 B1 FR 2926994B1 FR 0800625 A FR0800625 A FR 0800625A FR 0800625 A FR0800625 A FR 0800625A FR 2926994 B1 FR2926994 B1 FR 2926994B1
Authority
FR
France
Prior art keywords
preparation
new process
ginkgo biloba
biloba extracts
extracts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR0800625A
Other languages
English (en)
French (fr)
Other versions
FR2926994A1 (fr
Inventor
Beng Poon Teng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MAYOLY PHARMA FRANCE, FR
Original Assignee
Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39731553&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR2926994(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS filed Critical Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority to FR0800625A priority Critical patent/FR2926994B1/fr
Priority to JP2010545526A priority patent/JP5710271B2/ja
Priority to PCT/FR2009/000137 priority patent/WO2009112709A2/fr
Priority to CN2009801044220A priority patent/CN101939016B/zh
Priority to KR1020107019665A priority patent/KR20100113619A/ko
Priority to EP09720028.1A priority patent/EP2249847B1/fr
Priority to ES09720028.1T priority patent/ES2632507T3/es
Priority to EA201070924A priority patent/EA022346B1/ru
Priority to UAA201010750A priority patent/UA100257C2/uk
Publication of FR2926994A1 publication Critical patent/FR2926994A1/fr
Publication of FR2926994B1 publication Critical patent/FR2926994B1/fr
Application granted granted Critical
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Extraction Or Liquid Replacement (AREA)
  • Medicinal Preparation (AREA)
FR0800625A 2008-02-06 2008-02-06 Nouveau procede pour la preparation d'extraits de ginkgo biloba Active FR2926994B1 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FR0800625A FR2926994B1 (fr) 2008-02-06 2008-02-06 Nouveau procede pour la preparation d'extraits de ginkgo biloba
ES09720028.1T ES2632507T3 (es) 2008-02-06 2009-02-06 Nuevo procedimiento para la preparación de extractos de ginkgo biloba
PCT/FR2009/000137 WO2009112709A2 (fr) 2008-02-06 2009-02-06 Nouveau procede pour la preparation d'extraits de ginkgo biloba
CN2009801044220A CN101939016B (zh) 2008-02-06 2009-02-06 制备银杏提取物的方法
KR1020107019665A KR20100113619A (ko) 2008-02-06 2009-02-06 은행나무 추출물의 신규 제조 방법
EP09720028.1A EP2249847B1 (fr) 2008-02-06 2009-02-06 Nouveau procede pour la preparation d'extraits de ginkgo biloba
JP2010545526A JP5710271B2 (ja) 2008-02-06 2009-02-06 イチョウのエキスを製造する新規な方法
EA201070924A EA022346B1 (ru) 2008-02-06 2009-02-06 СПОСОБ ПОЛУЧЕНИЯ ЭКСТРАКТА Ginkgo biloba, ЭКСТРАКТ, ПОЛУЧЕННЫЙ ЭТИМ СПОСОБОМ, И ЕГО ПРИМЕНЕНИЕ
UAA201010750A UA100257C2 (uk) 2008-02-06 2009-06-02 Спосіб приготування екстрактів із ginkgo biloba

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0800625A FR2926994B1 (fr) 2008-02-06 2008-02-06 Nouveau procede pour la preparation d'extraits de ginkgo biloba

Publications (2)

Publication Number Publication Date
FR2926994A1 FR2926994A1 (fr) 2009-08-07
FR2926994B1 true FR2926994B1 (fr) 2010-08-27

Family

ID=39731553

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0800625A Active FR2926994B1 (fr) 2008-02-06 2008-02-06 Nouveau procede pour la preparation d'extraits de ginkgo biloba

Country Status (9)

Country Link
EP (1) EP2249847B1 (https=)
JP (1) JP5710271B2 (https=)
KR (1) KR20100113619A (https=)
CN (1) CN101939016B (https=)
EA (1) EA022346B1 (https=)
ES (1) ES2632507T3 (https=)
FR (1) FR2926994B1 (https=)
UA (1) UA100257C2 (https=)
WO (1) WO2009112709A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20090548A1 (it) * 2009-04-06 2010-10-07 Indena Spa Processo di rimozione di pesticidi da estratti di ginkgo biloba e estratti ottenibili da detto processo
KR101898709B1 (ko) * 2016-09-27 2018-09-13 주식회사 한성바이오파마 수용성 은행잎 추출액 및 추출분말의 제조방법
DE102023131617A1 (de) 2023-11-14 2025-05-15 Dr. Willmar Schwabe Gmbh & Co. Kg Verfahren zur Herstellung von Ginkgoextrakten mit hohem Gehalt an Proanthocyanidinen und Nahrungsergänzungsmittel und Arzneimittel enthaltend Ginkgoextrakte
FR3156652A1 (fr) * 2023-12-18 2025-06-20 Beng Poon Teng Procédé de préparation d’un extrait de feuilles de ginkgo biloba hautement enrichi en proanthocyanidins depourvu de flavonoïdes et de trilactones terpéniques

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR940002796B1 (ko) * 1989-06-16 1994-04-02 주식회사 선경인더스트리 은행잎에서 징코라이드를 분리 및 정제하는 방법
DE3940091A1 (de) 1989-12-04 1991-06-06 Schwabe Willmar Gmbh & Co Extrakt aus blaettern von ginkgo biloba, verfahren zu seiner herstellung und den extrakt enthaltende arzneimittel
DE19756848C2 (de) 1997-12-19 2003-01-16 Schwabe Willmar Gmbh & Co Extrakte aus Blättern von Ginkgo biloba mit vermindertem Gehalt an 4'-O-Methylpyridoxin und Biflavonen
FR2823116B1 (fr) * 2001-04-10 2004-11-19 Sod Conseils Rech Applic Procede de preparation d'une extrait de feuilles de ginkgo biloba hautement enrichi en principes actifs
US20060006765A1 (en) * 2004-07-09 2006-01-12 Jongtae Yuk Apparatus and method to transmit and receive acoustic wave energy
EP1868626B1 (en) * 2005-05-03 2008-09-10 Dr. Willmar Schwabe GmbH & Co. KG Improved method for preparing ginkgo extracts having a reduced content of polycyclic aromatic hydrocarbons
WO2006117168A2 (de) * 2005-05-03 2006-11-09 Dr. Willmar Schwabe Gmbh & Co. Kg Verfahren zur herstellung von ginkgoextrakten mit vermindertem gehalt an unpolaren pflanzeninhaltsstoffen und umweltbedingten unpolaren fremdstoffen
CN1891242B (zh) * 2005-07-06 2012-01-04 徐州技源天然保健品有限公司 一种从银杏叶提取物中脱除多环芳烃的生产工艺

Also Published As

Publication number Publication date
EA201070924A1 (ru) 2010-12-30
EP2249847A2 (fr) 2010-11-17
CN101939016B (zh) 2013-09-18
WO2009112709A2 (fr) 2009-09-17
UA100257C2 (uk) 2012-12-10
FR2926994A1 (fr) 2009-08-07
JP5710271B2 (ja) 2015-04-30
KR20100113619A (ko) 2010-10-21
WO2009112709A3 (fr) 2010-05-06
EA022346B1 (ru) 2015-12-30
EP2249847B1 (fr) 2017-04-12
ES2632507T3 (es) 2017-09-13
CN101939016A (zh) 2011-01-05
JP2011511047A (ja) 2011-04-07

Similar Documents

Publication Publication Date Title
FR2915201B1 (fr) Procede pour la preparation d'anhydrides polyalcenylsucciniques
FR2941817B1 (fr) Procede pour la preparation d'une composition d'electrode
ZA201006868B (en) Aminodihydrothiazine derivatives as bace inhibitors for the treatment of alzheimer's disease
EP2559262A4 (en) CONVERTER TO STAPEDIUS MONITORING
EP2240470A4 (en) IMPROVED AND NEW PROCESS FOR THE PRODUCTION OF BOSENTANE
EP2343357A4 (en) LUBRICANTS COMPOSITION AND MANUFACTURING METHOD THEREFOR
EP2603850A4 (en) METHOD FOR AUTHENTICATING PHARMACEUTICAL FORMS
FR2962731B1 (fr) Procede de preparation de derives d'amino-benzoyl-benzofurane
EP2408796A4 (en) APOLIPOPROTEIN B-TARGETINE FOR REDUCING APOLIPOPROTEIN C-III
FR2934857B1 (fr) Nouveau procede de synthese de l'agomelatine
FR2947186B1 (fr) Procede de preparation d'une emulsion huile-dans-eau stable
FR2934859B1 (fr) Nouveau procede de synthese de l'agomelatine
BRPI1015441A2 (pt) "composição compreendendo ácidos cafeoilxiquímicos, ácido protocatechuico hidroxitirosol, ácido hidroxibenzóico e seus derivados, e método de sua preparação"
FR2939699B1 (fr) Procede de preparation de nanoparticules lipidiques
FR2923484B1 (fr) Procede de preparation de composes morphiniques
GB0819141D0 (en) Production of Delta 9 Tetrahydrocannabinol
EP1976844A4 (en) IMPROVED METHOD FOR PURE DULOXETIN HYDROCHLORIDE
FR2947265B1 (fr) Procede de preparation d'alkylalcanolamines
EP2236137A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF FAT TEMPERATURE DISEASES
IL211975A (en) Process for the preparation of 9-dichloromethylene-1,2,3,4-tetrahydro-1,4-methano-naphthalene-5-ylamine and intermediate compounds
EP2491019A4 (en) METHOD AND COMPOSITIONS FOR PANIC DISORDER
FR2926994B1 (fr) Nouveau procede pour la preparation d'extraits de ginkgo biloba
BRPI1012007A2 (pt) "método para a preparação de ácido 2-ceto-carboxílico"
EP2421875A4 (en) HIGHLY SELECTIVE METHOD FOR THE PRODUCTION OF ORGANODIPHOSPHITES
MA31830B1 (fr) Nouveau procede de synthese de l'agomelatine

Legal Events

Date Code Title Description
CA Change of address
CD Change of name or company name
PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

TP Transmission of property

Owner name: IPSEN CONSUMER HEALTHCARE, FR

Effective date: 20210706

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18

CA Change of address

Effective date: 20250603

CD Change of name or company name

Owner name: MAYOLY PHARMA FRANCE, FR

Effective date: 20250603

PLFP Fee payment

Year of fee payment: 19